Clinical Trial Update: Chidamide in Combination With Vincristine Metronomic Chemotherapy for Advanced Triple-negative Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for chidamide in combination with vincristine metronomic chemotherapy in advanced triple-negative breast cancer, currently in Phase 1/Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Chidamide (chidamide)
• Vincristine (vincristine)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Breast Cancer, Chemotherapy Effect | Phase 1, Phase 2 | Status: UNKNOWN